General Information of the Compound
Compound ID
CP0919485
Compound Name
(1R,2S)-N-Oleoylcyclopropanolamide
    Show/Hide
Synonyms
(1R,2S)-N-Oleoylcyclopropanolamide
    Show/Hide
Structure
Formula
C19H37NO2
Molecular Weight
311.51
Canonical SMILES
CCCCCCCCCCCCCCCC(=O)N[C@H]1C[C@H]1O
    Show/Hide
InChI
InChI=1S/C19H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)20-17-16-18(17)21/h17-18,21H,2-16H2,1H3,(H,20,22)/t17-,18+/m0/s1
    Show/Hide
InChIKey
LIBNBUULGCFJNR-ZWKOTPCHSA-N
Physicochemical Property
logP
4.7171
Rotatable Bonds
15
Heavy Atom Count
22
Polar Areas
49.33
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44591632
ChEMBL ID
CHEMBL483143
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 820 nM
   TI
   LI
   LO
   TS
Protein ID: PT00834, Cannabinoid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1630 nM
   TI
   LI
   LO
   TS
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 180 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( (1R,2S)-N-Oleoylcyclopropanolamide )
Drug Name (1R,2S)-N-Oleoylcyclopropanolamide
Target(s)
Cannabinoid receptor 1 (CB1)
Inhibitor
Cannabinoid receptor 2 (CB2)
Inhibitor